FLT3 Inhibitor Improves AML Survival With or Without Stem-Cell Transplant

(MedPage Today) -- HOUSTON -- Post-transplant maintenance with an FLT3 inhibitor significantly improved overall survival (OS) in FLT3-positive acute myeloid leukemia (AML), according to a subgroup analysis of a randomized trial. Patients who...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news